SRPT - Financial Reports List - Sarepta Therapeutics, Inc. - IntrinsicAlpha

Sarepta Therapeutics, Inc. SRPT

Healthcare - Biotechnology - NASDAQ - US

$ 52.4

-3.73 %

$ 5.08 B

Market Cap

22.39

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	65.94%	248.37%	556.57%
Annual Report	FY	10-K	2024-12-31	52.97%	143.89%	181.43%
Quarterly Report	Q3	8-K	2024-09-30	40.79%	182.10%	206.50%
Quarterly Report	Q2	8-K	2024-06-30	38.93%	126.98%	99.47%
Quarterly Report	Q1	8-K	2024-03-31	63.10%	106.99%	125.28%
Quarterly Report	Q4	8-K	2023-12-31	53.54%	141.79%	123.05%
Annual Report	FY	10-K	2023-12-31	33.26%	23.81%	50.05%
Quarterly Report	Q3	8-K	2023-09-30	44.10%	84.12%	84.13%
Quarterly Report	Q2	8-K	2023-06-30	11.89%	89.66%	36.76%
Quarterly Report	Q1	8-K	2023-03-31	20.24%	-392.03%	-58.94%

1